Roster, K. I. O., Rönn, M. M., Gorenburg, E. R., Partl, D. K., Anderegg, N., Wiesch, P. A. z., . . . Low, N. (2026). Local Prevalence of Ceftriaxone Resistance Informs Optimal Deployment of New Gonorrhea Treatments. Open Forum Infectious Diseases, 13(7), 1. https://doi.org/10.1093/ofid/ofag447
Chicago Style (17th ed.) CitationRoster, Kirstin I Oliveira, et al. "Local Prevalence of Ceftriaxone Resistance Informs Optimal Deployment of New Gonorrhea Treatments." Open Forum Infectious Diseases 13, no. 7 (2026): 1. https://doi.org/10.1093/ofid/ofag447.
MLA (9th ed.) CitationRoster, Kirstin I Oliveira, et al. "Local Prevalence of Ceftriaxone Resistance Informs Optimal Deployment of New Gonorrhea Treatments." Open Forum Infectious Diseases, vol. 13, no. 7, 2026, p. 1, https://doi.org/10.1093/ofid/ofag447.